По вашему запросу найдено документов: 124

Страница 7 из 13

Counseling about sudden unexpected death in epilepsy (SUDEP): A global survey of neurologists' opinions
Asadi-Pooya, AA, Trinka, E, Brigo, F, Hingray, C, Karakis, I, Lattanzi, S, Valente, KD, Contreras, G, Turuspekova, ST, Kishk, NA, Aljandeel, G, Farazdaghi, M, Lopez, YC, Kissani, N, Triki, C, Kramer, G, Surges, R, Mesraoua, B, Yu, HY, Daza-Restrepo, A, Alsaadi, T, Al-Asmi, A, Kutlubaev, MA, Pretorius, C, Jusupova, A, Khachatryan, SG, Ranganathan, LN, Ashkanani, A, Tomson, T, Gigineishvili, D (2022)
in an academic setting were factors associated with a comfortable discussion about SUDEP. There were significant
Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа
Immune system changes in the pathogenesis of neurofibromatosis type 1
Mustafin, R.N., Мустафин, Р.Н. (2022)
of neurofibromas is associated with the fact that NF1-/ - Schwann cells stimulate the migration of mast cells
Endovascular Treatment of Acute Ischemic Stroke Due to Isolated Proximal Posterior Artery Occlusion
Zhang, G., Zhu, Y., Ling, Y., Chen, P., Dai, J., Wang, Ch., Xu, Sh., Shumadalova, A., Shi, H. (2022)
) occlusion is rare but associated with high morbidity and mortality rates. However, the optimal treatment
Skeletal anomalies in patients with neurofibromatosis type 1
Mustafin, R.N. (2022)
pathology, which is associated with the role of the NF1 gene in the development of connective tissue
Circulating ciRS-7 as a potential non-invasive biomarker for epithelial ovarian cancer: An investigative study
Beilerli, Aferin, Begliarzade, Sema, Sufianov, Albert, Ilyasova, Tatiana, Liang, Yanchao, Beylerli, Ozal (2022)
is associated with lymph node invasion, FIGO stage, distant metastasis, and worse overall survival (OS
Prospects for the treatment of neurofibromatosis type 1: A review
Mustafin, R.N., Мустафин, Р.Н. (2022)
Medical Association. All rights reserved.
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Onorato, Eustaquio Maria, Onorato, Eustaquio Maria, Muratori, Manuela, Smolka, Grzegorz, Wojakowski, Wojtek, Pysz, Piotr, Zorinas, Aleksejus, Zakarkaite, Diana, Eltchaninoff, Hélène, Litzer, Pierre-Yves, Godart, François, Calvert, Patrick, Christou, Christos, Mussayev, Abdurashid, Missiroli, Bindo, Buzaev, Igor, Curello, Salvatore, Tesorio, Tullio, Bartorelli, Antonio Luca (2022)
failure (HF), classified as New York Heart Association (NYHA) class III/IV, decreased from 80% at baseline
Bioinformatics analysis of potential therapeutic targets for COVID-19 infection in patients with carotid atherosclerosis
Yanchao, L., Sibin, Z., Gareev, I., Huan, X., Junfei, Z., Chunyang, L., Beylerli, O., Sufianov, A., Chao, Y., Yuyan, G., Xun, X., Ahmad, A. (2022)
: With COVID-19 being a relatively new disease, associations have been proposed for its connections
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
Maniatis, AK;, Casella, SJ;, Nadgir, UM;, Hofman, PL;, Saenger, P;, Chertock, ED;, Aghajanova, EM;, Korpal-Szczyrska, M;, Vlachopapadopoulou, E;, Malievskiy, O;, Chaychenko, T;, Cappa, M;, Song, WJ;, Mao, M;, Mygind, PH;, Smith, AR;, Chessler, S;, Komirenko, AS;, Beckert, M;, Aimee, D Shu, Paul, S Thornton (2022)
and tolerability. Results: Lonapegsomatropin treatment during enliGHten was associated with continued improvements
Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
Wu, JN, Al-Zahrani, A, Beylerli, O, Sufianov, R, Talybov, R, Meshcheryakova, S, Sufianova, G, Gareev, I, Sufianov, A (2022)
circulating miR-155 and lower miR-181a/b and miR-410 expression is associated with clinical data, clinic

Страница 7 из 13

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год